Republic of China (Taiwan) Pharmaceutical Market Worth $8.4 Billion with 6.4% CAGR by 2020
The "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Republic of China (Taiwan)" is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in the Republic of China (Taiwan). Taiwan's population increased slightly between 2008 and 2013 from 23.0 to 23.4 million, mainly due to a rising life expectancy. However, the birth rate decreased at a negative Compound Annual Growth Rate (CAGR) of 0.2%. The pharmaceutical market was estimated at $5.4 billion in 2013 and is...
View full press release